<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quest Diagnostics &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/quest-diagnostics/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Mon, 25 Oct 2021 09:07:18 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>Quest Diagnostics &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2020-2025年全球MRD检测市场分析及预测报告(2020年全球MRD市场规模达约8亿美元)</title>
		<link>https://www.yuanzhezixun.com/2020-2025nianquanqiu-mrdjiance/</link>
		
		<dc:creator><![CDATA[Timlee]]></dc:creator>
		<pubDate>Mon, 11 Oct 2021 09:10:58 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Adaptive Biotechnologies Corporation]]></category>
		<category><![CDATA[ArcherDX]]></category>
		<category><![CDATA[Arup Laboratories]]></category>
		<category><![CDATA[ASURAGEN INC.]]></category>
		<category><![CDATA[Bio-Rad Laboratories]]></category>
		<category><![CDATA[Cergentis B.V.]]></category>
		<category><![CDATA[Guardant Health]]></category>
		<category><![CDATA[ICON plc]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[Inivata]]></category>
		<category><![CDATA[Invitae Corporation]]></category>
		<category><![CDATA[Invivoscribe]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[Mission Bio]]></category>
		<category><![CDATA[MRD检测]]></category>
		<category><![CDATA[Natera]]></category>
		<category><![CDATA[NeoGenomics Laboratories]]></category>
		<category><![CDATA[NGS]]></category>
		<category><![CDATA[Opko Health]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[Sysmex Corporation]]></category>
		<category><![CDATA[二代测序]]></category>
		<category><![CDATA[体外诊断]]></category>
		<category><![CDATA[流式细胞仪]]></category>
		<category><![CDATA[聚合酶链式反应]]></category>
		<category><![CDATA[肿瘤检测]]></category>
		<category><![CDATA[血液检测]]></category>
		<category><![CDATA[诊断试剂]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=27658</guid>

					<description><![CDATA[据CRI元哲分析，MRD检测行业是发展最迅速、最活跃的市场之一。

该市场受益于血液恶性肿瘤和实体瘤的MRD检测解决方案领域的发展。目前，血液恶性肿瘤发病率上升，引发了敏感检测解决方案的大量需求，从而导致MRD检测行业飙升。此外，患者对MRD检测的高度认可，以及医生对MRD检测的认识不断提高等关键因素也有望促进市场增长。

据CRI元哲分析，2020年全球MRD市场规模已经达到约8.03亿美元，预计在2021-2025年，全球MRD检测市场将以15.6%的复合年增长率增长。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>全球鸡蛋过敏市场研究报告预测到2023年</title>
		<link>https://www.yuanzhezixun.com/quanqiujidanguominshichangyanjiubaogaoyucedao2023nian/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 23 Apr 2019 06:18:31 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Alletess Medical Laboratory]]></category>
		<category><![CDATA[Creative Diagnostics]]></category>
		<category><![CDATA[Genentech]]></category>
		<category><![CDATA[HYCOR Biomedical]]></category>
		<category><![CDATA[ImmuneTech]]></category>
		<category><![CDATA[Imutest Ltd]]></category>
		<category><![CDATA[Kaleo]]></category>
		<category><![CDATA[Mylan N. V.]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[Sanofi S.A.]]></category>
		<category><![CDATA[鸡蛋过敏]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=19495</guid>

					<description><![CDATA[到2023年，全球鸡蛋过敏市场预计将从2018年的1,635.3百万美元达到230.43亿美元;在2018年至2023年的预测期内，预计其复合年均复合增长率为7.10％。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>全球精准医药市场（2018-2023）</title>
		<link>https://www.yuanzhezixun.com/quanqiujingzhunyiyaoshichang2018-2023/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 16 Apr 2019 03:21:53 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Almac Group]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[GlaxoSmithKline (GSK)]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Novartis AG.]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[Randox Laboratories]]></category>
		<category><![CDATA[Teva Pharmaceutical industries]]></category>
		<category><![CDATA[精准医药]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=19051</guid>

					<description><![CDATA[全球精准医药市场受益于生命科学行业的进步。尽管处于初期阶段，但由于有可能治疗和治疗慢性疾病，因此靶向治疗在未来几年中有很大的机会成功取得巨大成功。因此预计2018年至2023年期间市场将以11.60％的复合年增长率（CAGR）扩张，到2023年将产生88.25亿美元的收入。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>全球非酒精性脂肪性肝炎（NASH）诊断市场（2018-2023）</title>
		<link>https://www.yuanzhezixun.com/quanqiufeijiujingxingzhifangxingganyannashzhenduanshichang2018-2023/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 16 Apr 2019 02:50:11 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[BioPredictive]]></category>
		<category><![CDATA[Echosens]]></category>
		<category><![CDATA[Exalenz Bioscience]]></category>
		<category><![CDATA[GENFIT]]></category>
		<category><![CDATA[NASH]]></category>
		<category><![CDATA[One Way Liver]]></category>
		<category><![CDATA[Prometheus Laboratories]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[Siemens Healthcare]]></category>
		<category><![CDATA[SuperSonic Imagine]]></category>
		<category><![CDATA[VLVbio]]></category>
		<category><![CDATA[非酒精性脂肪性肝炎]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=19035</guid>

					<description><![CDATA[NASH影响了全世界约12％的成年人口。超过80％的NASH患者肥胖，44％患有2型糖尿病，72％的患者血脂异常（甘油三酯和胆固醇）。这些疾病越来越普遍，预计将推动2018 - 2023年期间对NASH诊断的需求。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>2018-2023年中国癌症筛查市场研究报告</title>
		<link>https://www.yuanzhezixun.com/2018-2023nianzhongguoaizhengshaichashichangyanjiubaogao/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Mon, 15 Oct 2018 04:00:15 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[F. Hoffmann-La Roche AG]]></category>
		<category><![CDATA[Hologic Inc.]]></category>
		<category><![CDATA[Qiagen]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[癌症筛查]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=15817</guid>

					<description><![CDATA[在过去十年中，中国对癌症筛查的需求增长迅速。癌症是中国最重要的医疗保健负担之一。由于资本投资的连续增长，中国经济保持了高速增长。到2023年，中国的癌症筛查市场预计将达到15亿美元，复合年增长率为14％。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
